Esperion Therapeutics Eulerpool Novinky

Esperion Therapeutics Eulerpool News

Esperion Therapeutics Novinky o akciách

Esperion Therapeutics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Esperion Therapeutics zhromažďujeme práve tu.

• 11. septembra ·

  Yahoo
  Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?
• 5. septembra ·

  Yahoo
  Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
• 4. septembra ·

  Stock Options Channel
  Commit To Purchase Esperion Therapeutics At $1.50, Earn 36% Annualized Using Options
• 3. septembra ·

  Yahoo
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe)
• 3. septembra ·

  TipRanks
  Market Outperform: Enhanced Insurance Coverage and FDA Approvals Propel Esperion’s Growth Potential
• 3. septembra ·

  GlobeNewswire
  Esperion Secures Additional Commercial and Medicare Formulary Coverage for NEXLETOL? (bempedoic acid) and NEXLIZET? (bempedoic acid and ezetimibe)
• 3. septembra ·

  Thefly.com
  Esperion secures additional commercial, Medicare formulary coverage for NEXLETOL
• 26. augusta ·

  Yahoo
  Esperion to Participate in Upcoming H.C. Wainwright 26th Annual Global Investment Conference
• 19. augusta ·

  SeekingAlpha
  Esperion Therapeutics: Delivering On Expectations While Navigating Overhangs
• 16. augusta ·

  SeekingAlpha
  Esperion Therapeutics: Strategically Positioned To Grow